Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
messenger RNA
Biotech
Wave hails human RNA editing first for GSK-partnered prospect
The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14.
Nick Paul Taylor
Oct 16, 2024 10:22am
Moderna slashes R&D spending, drops 5 programs
Sep 12, 2024 8:10am
CureVac gains $430M GSK vaccine contract, loses 30% of staff
Jul 3, 2024 5:00am
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial
Oct 31, 2023 7:53am
Pfizer, BioNTech prep flu-COVID mRNA combo vaccine for phase 3
Oct 26, 2023 9:32am
Sanofi, BioNTech scrap mRNA cancer drug based on early data
Jul 28, 2023 6:53am
